Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
Kezar Life Sciences Net Income (TTM) : -45.23M for March 31, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -45.23M |
| December 31, 2025 | -56.03M |
| September 30, 2025 | -61.70M |
| June 30, 2025 | -70.79M |
| March 31, 2025 | -78.63M |
| December 31, 2024 | -83.74M |
| September 30, 2024 | -95.78M |
| June 30, 2024 | -98.57M |
| March 31, 2024 | -101.33M |
| December 31, 2023 | -101.87M |
| September 30, 2023 | -87.79M |
| June 30, 2023 | -82.54M |
| March 31, 2023 | -74.41M |
| December 31, 2022 | -68.24M |
| September 30, 2022 | -64.27M |
| June 30, 2022 | -60.88M |
| March 31, 2022 | -57.66M |
| Date | Value |
|---|---|
| December 31, 2021 | -54.63M |
| September 30, 2021 | -51.36M |
| June 30, 2021 | -48.19M |
| March 31, 2021 | -44.72M |
| December 31, 2020 | -41.74M |
| September 30, 2020 | -40.38M |
| June 30, 2020 | -38.24M |
| March 31, 2020 | -37.46M |
| December 31, 2019 | -35.09M |
| September 30, 2019 | -31.29M |
| June 30, 2019 | -27.80M |
| March 31, 2019 | -25.86M |
| December 31, 2018 | -23.17M |
| September 30, 2018 | -19.68M |
| June 30, 2018 | -16.10M |
| March 31, 2018 | -11.21M |
| December 31, 2017 | -8.517M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| NovelStem International Corp. | -0.3076M |
| Brainstorm Cell Therapeutics, Inc. | -10.52M |
| Summit Therapeutics, Inc. | -856.09M |
| Protara Therapeutics, Inc. | -70.02M |
| Clene, Inc. | -39.52M |